Advanced search
Publication Cover
Journal of Hepatocellular Carcinoma Volume 9, 2022 - Issue
Submit an article Journal homepage
115
Views
3
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Hepatic Arterial Infusion Chemotherapy as a Timing Strategy for Conversion Surgery to Treat Hepatocellular Carcinoma: A Single-Center Real-World Study

Jiongliang Wang1 Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, People’s Republic of China;2 Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, People’s Republic of ChinaView further author information
,
Zhikai Zheng1 Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, People’s Republic of China;2 Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, People’s Republic of ChinaView further author information
,
Tianqing Wu1 Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, People’s Republic of China;2 Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, People’s Republic of ChinaView further author information
,
Wenxuan Li1 Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, People’s Republic of China;2 Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, People’s Republic of ChinaView further author information
,
Juncheng Wang1 Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, People’s Republic of China;2 Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, People’s Republic of ChinaView further author information
,
Yangxun Pan1 Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, People’s Republic of China;2 Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-3887-5852View further author information
ORCID Icon,
Wei Peng1 Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, People’s Republic of China;2 Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, People’s Republic of ChinaView further author information
,
Dandan Hu1 Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, People’s Republic of China;2 Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, People’s Republic of ChinaView further author information
,
Jiajie Hou1 Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, People’s Republic of China;2 Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, People’s Republic of ChinaView further author information
,
Li Xu1 Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, People’s Republic of China;2 Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0003-4405-1048View further author information
ORCID Icon,
Yaojun Zhang1 Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, People’s Republic of China;2 Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-9752-4729View further author information
ORCID Icon,
Minshan Chen1 Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, People’s Republic of China;2 Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, People’s Republic of ChinaView further author information
,
Rongxin Zhang2 Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, People’s Republic of China;3 Department of Colorectal Surgery, Sun Yat-sen University Cancer Center, Guangzhou, People’s Republic of ChinaCorrespondence[email protected]
View further author information
&
Zhongguo Zhou1 Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, People’s Republic of China;2 Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, People’s Republic of ChinaCorrespondence[email protected]
View further author information
 show all
Pages 999-1010 | Received 28 Jun 2022, Accepted 09 Sep 2022, Published online: 14 Sep 2022

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Zhenyun Yang, Zili Hu, Yizhen Fu, Dandan Hu, Zhongguo Zhou, Minshan Chen, Yangxun Pan & Yaojun Zhang. (2023) Laparoscopic Hepatectomy versus Open Hepatectomy After Conversion Therapy Using Transarterial Chemoembolization or Hepatic Arterial Infusion Chemotherapy for Patients with Initially Unresectable Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 10, pages 1157-1167.
Read now

Articles from other publishers (2)

Chao An, Yan Fu, Wang Li, Mengxuan Zuo & Peihong Wu. (2023) Postprogression treatment of lenvatinib plus PD‐1 inhibitor in advanced hepatocellular carcinoma refractory to hepatic arterial infusion chemotherapy. Cancer 129:14, pages 2235-2244.
Crossref
Diyang Xie, Jieyi Shi, Jian Zhou, Jia Fan & Qiang Gao. (2023) Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Chinese perspective. Clinical and Molecular Hepatology 29:2, pages 206-216.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.